Fig. 2From: Severe obesity in a specialist type 2 diabetes outpatient clinic: an Australian retrospective cohort studyUse of different classes of medications. DPP4i – Dipeptidyl-Peptidase 4, GLP1a – Glucagon-like Peptide 1 agonist, SGLT2i – Sodium/glucose Co-transporter 2 inhibitorBack to article page